ZhuZhou QianJin Pharmaceutical Co., Ltd Assigned Short-Term Ba2 & Long-Term Baa2 Credit Rating

For these reasons, although the criteria establish no rating threshold for liquidity, we typically expect: Instances of 'B+' and below rated issuers achieving liquidity descriptors higher than adequate to be rare and Few companies to qualify for the exceptional category, and these entities to typically have issuer credit ratings of 'BBB-' or above.ZhuZhou QianJin Pharmaceutical Co., Ltd Assigned Short-Term Ba2 & Long-Term Baa2 Credit Rating. How Does Credit Rating Model Work?

Rating Model for ZhuZhou QianJin Pharmaceutical Co., Ltd: We estimate the credit risk parameters by Sustainability and Simple Regression

Credit Ratings for ZhuZhou QianJin Pharmaceutical Co., Ltd as of 02 Apr 2022

Credit Rating	Short-Term	Long-Term Senior
AI Rating Class*	Ba2	Baa2
Semantic Signals	88	71
Financial Signals	46	44
Risk Signals	74	87
Substantial Risks	67	87
Speculative Signals	68	72

*Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines.Take a look at: How Does Credit Rating Model Work?

Financial Analysis for ZhuZhou QianJin Pharmaceutical Co., Ltd

Financials: PREMIUM
Income Statement: PREMIUM
Balance Sheet: PREMIUM
Cash Flow: PREMIUM
Valuation: PREMIUM
Inventory Valuation: PREMIUM
Dividends: PREMIUM
Operating Performance: PREMIUM
Sustainability: PREMIUM
Price vs. Fair Value: PREMIUM
Stock Analysis: PREMIUM

Analyst Rating for ZhuZhou QianJin Pharmaceutical Co., Ltd

Is it the right time to buy or sell? : PREMIUM
Fair Value : PREMIUM
Trailing Returns : PREMIUM

Key Statistics for ZhuZhou QianJin Pharmaceutical Co., Ltd

Price/Book : PREMIUM
Price/Cash Flow : PREMIUM
Price/Sales : PREMIUM
Price/Earnings : PREMIUM
Operating Income : PREMIUM
Net Income : PREMIUM
Quick Ratio : PREMIUM
Current Ratio : PREMIUM
Interest Coverage : PREMIUM
Debt/Equity : PREMIUM
Return on Assets : PREMIUM
Return on Equity : PREMIUM
Invested Capital : PREMIUM
Net Margin : PREMIUM
EBITDA Margin : PREMIUM
Days Sales Outstanding : PREMIUM
Payables Period : PREMIUM
Cash Conversion Cycle : PREMIUM
Recieveables Turnover : PREMIUM
Inventory Turnover : PREMIUM
Fixed Assets Turnover : PREMIUM
Asset Turnover : PREMIUM
Operating Cash Flow Growth : PREMIUM
Free Cash Flow Growth : PREMIUM
Free Cash Flow/Sales : PREMIUM
Free Cash Flow/Net Income : PREMIUM
Free Cash Flow/Share : PREMIUM

Credit Report for ZhuZhou QianJin Pharmaceutical Co., Ltd

Risk Report : PREMIUM
Credit Report : PREMIUM
Commercial Credit Report : PREMIUM

Audit Reports & Filings for ZhuZhou QianJin Pharmaceutical Co., Ltd

Audit Reports : PREMIUM
Principal Risk and Viability : PREMIUM
Risk Analysis : PREMIUM
Retail Technology Environment, Including IT Security : PREMIUM
SEC Filings : PREMIUM
Bankruptcy Filings : PREMIUM
Suit & Judgment Filings : PREMIUM
Tax Lien Filings : PREMIUM

Market Research for ZhuZhou QianJin Pharmaceutical Co., Ltd

Customer Reviews : 12370 reviews PREMIUM
Interviews : PREMIUM
Focus Groups : PREMIUM
Market Share Analysis : PREMIUM